Research Topics
Genomes and GenesSpecies | M BoeckhSummaryAffiliation: Fred Hutchinson Cancer Research Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Prevention of VZV infection in immunosuppressed patients using antiviral agentsMichael Boeckh
Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, University of Washington, Seattle, WA 98109, USA
Herpes 13:60-5. 2006..Current evidence on the use of antiviral agents in the prevention of reactivation disease and management of exposure to VZV is discussed...
Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugsHirohisa Nakamae
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Haematologica 96:1838-45. 2011..Etiologies include myelotoxic agents, viral infections, and possibly transplant-related factors such as the intensity of the conditioning regimen and the source of stem cells...
Quantitation of cytomegalovirus: methodologic aspects and clinical applicationsM Boeckh
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Clin Microbiol Rev 11:533-54. 1998..Due to the widespread use of quantitative CMV detection techniques to direct and monitor antiviral treatment, there is a great need for an assessment of the reproducibility of test results and better standardization of the assays...
Emerging viral infections after hematopoietic cell transplantationMichael Boeckh
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Pediatr Transplant 9:48-54. 2005..HHV-6 has been strongly associated with encephalitis and delayed platelet engraftment. Prospective studies are needed to further examine epidemiology, disease associations, and management strategies for these viruses...
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapyMichael Boeckh
Program in Ifectious Diseases, Fred Hutcinson Cancer Research Center and University of Washington, Settle, 98105, USA
Blood 103:2003-8. 2004..Prevention strategies may require targeting both the direct and indirect effects of CMV infection by immunologic or antiviral drug strategies...
The challenge of respiratory virus infections in hematopoietic cell transplant recipientsMichael Boeckh
Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, School of Medicine, University of Washington, Seattle, WA, USA
Br J Haematol 143:455-67. 2008..This article reviews the spectrum of pathogens, epidemiology, risk factors and clinical manifestations of infection, as well as recent advances in diagnostic and clinical management...
Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virusAlexandre A Boudreault
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Biol Blood Marrow Transplant 17:979-86. 2011..Antiviral therapy initiated during the URI phase reduced the risk of LRD and hypoxemia...
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunityMichael Boeckh
Program in Infectious Diseases Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Blood 101:407-14. 2003..Prevention strategies should be targeted at patients in whom CMV reactivated during the first 3 months and those with poor CMV-specific immunity or low CD4 counts...
How we treat cytomegalovirus in hematopoietic cell transplant recipientsMichael Boeckh
Vaccine and Infectious Disease Institute and Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Blood 113:5711-9. 2009....
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipientsMichael Boeckh
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Clin Infect Dis 44:245-9. 2007..Respiratory syncytial virus infection of the upper airways may progress to fatal pneumonia in hematopoietic cell transplant recipients. The safety and efficacy of aerosolized ribavirin in preventing disease progression is unknown...
Complications, diagnosis, management, and prevention of CMV infections: current and futureMichael Boeckh
Vaccine and Infectious Disease and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 4417, USA
Hematology Am Soc Hematol Educ Program 2011:305-9. 2011..This article reviews current aspects of CMV diagnosis, prevention, and treatment in HCT recipients and defines areas of unmet medical need...
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled studyMichael Boeckh
Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, 1100 Fairview Ave N, Seattle, WA 98109, USA
Blood 107:1800-5. 2006..Periods of prophylaxis longer than 12 months may be beneficial for those hematopoietic cell transplant recipients on continued immune suppression...
Effect of high-dose acyclovir on survival in allogeneic marrow transplant recipients who received ganciclovir at engraftment or for cytomegalovirus pp65 antigenemiaM Boeckh
Fred Hutchinson Cancer Research Center, Seattle, Program in Infectious Diseases, 98109 4417, USA
J Infect Dis 178:1153-7. 1998..Thus, high-dose acyclovir does not appear to improve survival when ganciclovir is given either at engraftment or for CMV pp65 antigenemia...
Rising CMV PP65 antigenemia and DNA levels during preemptive antiviral therapyMichael Boeckh
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington, USA
Haematologica 90:439. 2005
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCRMichael Boeckh
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington 98109 1024, USA
J Clin Microbiol 42:1142-8. 2004..Thus, primer optimization and improved DNA extraction techniques resulted in a plasma-based PCR assay that is significantly more sensitive than pp65 antigenemia and blood cultures for detection of CMV in blood specimens...
Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantationMichael Boeckh
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109, USA
Pediatr Transplant 8:19-27. 2004..The development of new drugs and immunologic strategies (adoptive transfer of CMV-specific T-cells and donor/recipient vaccination strategies) are important goals for the elimination of the negative impact of CMV in the HCT setting...
Current antiviral strategies for controlling cytomegalovirus in hematopoietic stem cell transplant recipients: prevention and therapyM Boeckh
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, Washington 98109 4417, USA
Transpl Infect Dis 1:165-78. 1999..Owing to continued clinical significance of CMV in the HSCT setting, new and more effective anti-CMV drugs with improved pharmacokinetic properties are urgently needed...
Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplantsM Boeckh
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 98109, USA
J Infect Dis 184:350-4. 2001..Thus, palivizumab appears to be safe and well tolerated in HSCT recipients...
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantationM Boeckh
Fred Hutchinson Cancer Research Center and University of Washington, Seattle 98109, USA
Biol Blood Marrow Transplant 7:343-51. 2001..Thus, there is no evidence that MSL-109 is beneficial in CMV-seropositive HSCT recipients...
Immunosuppressive effects of beta-herpesvirusesMichael Boeckh
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA
Herpes 10:12-6. 2003..More trials are needed to evaluate whether the effects seen in observational studies are truly related...
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantationHirohisa Nakamae
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Biol Blood Marrow Transplant 15:694-703. 2009..Therefore, CMV prevention strategies in NM-HCT recipients should be similar to those used in M-HCT recipients...
Risk factors for late-onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney transplant recipients who receive antiviral prophylaxisA A Boudreault
Department of Medicine, University of Washington, Seattle, Washington, USA
Transpl Infect Dis 13:244-9. 2011..Cytomegalovirus (CMV) disease occurs frequently after cessation of antiviral prophylaxis in CMV-seronegative kidney transplant recipients from seropositive donors (D+R-), and the risk factors are incompletely defined...
Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trialK A Marr
Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA 98109 1024, USA
Blood 96:2055-61. 2000....
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplantsA P Limaye
Department of Laboratory Medicine, University of Washington, Seattle 98195 7110, USA
Lancet 356:645-9. 2000..We retrospectively assessed the occurrence of ganciclovir-resistant cytomegalovirus disease among transplant recipients who had received oral ganciclovir prophylaxis and highly potent immunosuppression...
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantationJ Storek
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA, USA
Blood 97:3380-9. 2001..008). In conclusion, blood stem cell recipients have higher lymphocyte-subset counts and this appears to result in fewer infections. (Blood. 2001;97:3380-3389)..
Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipientsA P Limaye
Departments of Laboratory Medicine and Medicine, University of Washington, Seattle, WA 98195 7110, USA
J Infect Dis 183:377-82. 2001..5x107] vs. <50 [range, <50-350] CMV DNA copies/mL plasma, respectively; P<.001). Quantitative PCR for CMV DNA in plasma appears to be useful for the identification of HSCT recipients at risk for CMV disease before engraftment...
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control studyChristian Junghanss
Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109-1024, USA
Blood 99:1978-85. 2002..Therefore, nonmyeloablative HSCT patients should receive CMV surveillance beyond day 100 and pre-emptive ganciclovir treatment similar to that of myeloablative HSCT patients...
BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipientsVeronique Erard
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Program in Infectious Diseases, 1100 Fairview Ave North D3-100, PO Box 19024, Seattle, WA 98109-1024, USA
Blood 106:1130-2. 2005..BK virus seems to play a role in the development of HC and quantitative detection of BK DNA in plasma appears to be a marker of BK virus disease in HCT recipients...
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantationChristian Junghanss
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA
Br J Haematol 123:662-70. 2003....
Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: the Fred Hutchinson Cancer Research Center experienceW G Nichols
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Biol Blood Marrow Transplant 7:11S-15S. 2001..Two controlled clinical trials of ribavirin therapy for RSV infection in HSCT recipients are in progress...
Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donorsKai Hubel
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Transfusion 42:1414-21. 2002....
De novo chronic graft-versus-host disease in marrow graft recipients given methotrexate and cyclosporine: risk factors and survivalJ L Wagner
Clinical Research, Department of Medicine, University of Washington, Seattle, USA
Biol Blood Marrow Transplant 6:633-9. 2000....
Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipientsJanet A Englund
Children s Hospital and Regional Medical Center, University of Washington, and Fred Hutchinson Cancer Research Center, Seattle, Washington 98105, USA
Ann Intern Med 144:344-9. 2006..Human metapneumovirus (hMPV), a recently discovered respiratory virus, is associated with clinical disease in young and elderly persons...
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioningTakahiro Fukuda
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Blood 102:827-33. 2003..More effective strategies are needed to prevent invasive mold infections, which currently account for a notable proportion of nonrelapse mortality after nonmyeloablative allogeneic HCT...
Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortalityArlo Upton
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 98109, USA
Clin Infect Dis 44:531-40. 2007..The aim of this study was to determine the probability of survival and prognostic factors associated with outcomes over a long period of time...
Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionAngela J Peck
Department of Pediatrics, Children s Hospital and Regional Medical Center and University of Washington, Seattle, WA, USA
Blood 110:1681-8. 2007..004). Subclinical infection with PIV may help explain why infection-control programs that emphasize symptoms are effective against RSV and influenza but often not against PIV...
Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV diseaseVeronique Erard
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
J Infect Dis 196:266-70. 2007..2% [95% CI, 0%-0.8%]; P=.006), and in 0 patients in cohort 3 (cohort 2 vs. cohort 3, P=.3). Long-term use of suppressive prophylactic ACV appears to prevent the emergence of drug-resistant HSV disease in HCT...
Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcomeW G Nichols
Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Ave N, Seattle, WA 98109-4417, USA
Blood 98:573-8. 2001..Currently available antiviral therapy appears to be inadequate in reducing viral shedding or mortality once pneumonia is established. (Blood. 2001;98:573-578)..
Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infectionYae Jean Kim
Division of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Semin Respir Crit Care Med 28:222-42. 2007..Clinicians should appreciate the potential for the development of antiviral resistance to influenza antivirals in immunocompromised patients...
Reduced mortality after allogeneic hematopoietic-cell transplantationTed A Gooley
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
N Engl J Med 363:2091-101. 2010..Over the past decade, advances have been made in the care of patients undergoing transplantation. We conducted a study to determine whether these advances have improved the outcomes of transplantation...
One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuationVeronique Erard
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Blood 110:3071-7. 2007..To effectively prevent VZV disease in long-term hematopoietic cell transplantation survivors, additional approaches such as vaccination will probably be required...
Airflow decline after myeloablative allogeneic hematopoietic cell transplantation: the role of community respiratory virusesVeronique Erard
Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109-1024, USA
J Infect Dis 193:1619-25. 2006..Thus, community respiratory virus-associated airflow decline seems to be specific to viral species and infection localization...
Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivationMorgan Hakki
Fred Hutchinson Cancer Research Center, and the University of Washington, Seattle, USA
Blood 102:3060-7. 2003..Subclinical CMV reactivation while on ganciclovir appears to be a potent stimulator of T-cell function. These findings have implications for vaccination and adoptive-immunotherapy strategies in this population...
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategiesMichael Boeckh
University of Washington, Seattle, WA 81009, USA
Biol Blood Marrow Transplant 9:543-58. 2003....
Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survivalBenedetto Bruno
Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA
Biol Blood Marrow Transplant 9:341-52. 2003..Ganciclovir, given for CMV prevention, may have a protective effect. Controlled treatment and prevention studies are warranted...
Cytomegalovirus reactivation in critically ill immunocompetent patientsAjit P Limaye
Department of Laboratory Medicine, University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195 7110, USA
JAMA 300:413-22. 2008....
Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive diseaseVeronique Erard
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 1024, USA
Clin Infect Dis 45:958-65. 2007..The value of adenovirus plasma DNA detection as an indicator for adenovirus disease is unknown in the context of T cell-replete hematopoietic cell transplantation, of which adenovirus disease is an uncommon but serious complication...
Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantationDanielle M Zerr
Department of Pediatrics, University of Washington, Seattle, Washington, USA
Clin Infect Dis 40:932-40. 2005..Although human herpesvirus 6 (HHV-6) is known to reactivate during hematopoietic stem cell transplantation (HSCT), the clinical significance of this finding is controversial...
Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control studyDebie Vu
Fred Hutchinson Cancer Research Center, Seattle, WA, 98109 1024, USA
Clin Infect Dis 45:187-93. 2007..However, no data exist regarding the use of oseltamivir as prophylaxis among patients undergoing hematopoietic stem cell transplantation (HSCT)...
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infectionW Garrett Nichols
Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109-4417, USA
J Infect Dis 185:273-82. 2002..However, in D(+)/R(-) subjects, mortality appears to be associated with bacterial and fungal infection, indicating a possible immunomodulatory effect of primary CMV infection that was undetected despite intensive monitoring...
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantationFulvio Crippa
Fred Hutchinson Cancer Research Center, Seattle Washington 98109-1024, USA
Biol Blood Marrow Transplant 8:281-9. 2002..Because the risk for infections approaches that seen in allogeneic transplant recipients, infection surveillance, diagnostic work-up, and prevention strategies similar to those used in allogeneic recipients are warranted...
Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipientsJ Kuypers
University of Washington, Seattle, Washington, USA
Transpl Infect Dis 11:298-303. 2009..To evaluate the relative sensitivity of respiratory virus detection in specimens from HCT recipients, we compared the results of conventional and quantitative molecular methods...
Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factorsKieren A Marr
Fred Hutchinson Cancer Research Center Programs in Infectious Diseases and Long term Follow up, Seattle, WA 98109, USA
Blood 100:4358-66. 2002....
High incidence of ganciclovir-resistant cytomegalovirus infection among lung transplant recipients receiving preemptive therapyAjit P Limaye
Department of Laboratory Medicine, University of Washington, Seattle, WA, USA
J Infect Dis 185:20-7. 2002..All ganR isolates contained a UL97 mutation. GanR CMV infection occurs in nearly 10% of lung transplant recipients, despite preemptive antiviral therapy, and is more common among D+/R- patients...
Combination antifungal therapy for invasive aspergillosisKieren A Marr
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
Clin Infect Dis 39:797-802. 2004..The results of in vitro studies and animal models suggest that combination therapy with azoles and echinocandins may have additive activity against Aspergillus species...
Persistent fever in patients with neutropeniaLawrence Corey
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
N Engl J Med 346:222-4. 2002
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromesBart L Scott
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Biol Blood Marrow Transplant 14:799-806. 2008..94 [1.0-3.8], P = .05), but not for overall mortality or NRM. We propose that intensified strategies to prevent infections should be implemented in MDS patients with preexisting neutropenia who undergo HSCT...
Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsW Garrett Nichols
Program in Infectious Diseases and Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Blood 101:4195-200. 2003..In an era of "universal leukoreduction," the abandonment of CMV-seronegative inventories appears premature, particularly among populations at high risk of CMV disease that do not receive active surveillance...
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomesMarco Mielcarek
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Blood 113:2888-94. 2009..We conclude that initial treatment with low-dose glucocorticoids for patients with grades I-II GVHD did not compromise disease control or mortality and was associated with decreased toxicity...
Factors affecting antibody levels after allogeneic hematopoietic cell transplantationJan Storek
Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Blood 101:3319-24. 2003....
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantationJoshua T Schiffer
Fred Hutchinson Cancer Research Center, Seattle, WA 98102, USA
Haematologica 94:1101-8. 2009....
Respiratory virus pneumonia after hematopoietic cell transplantation (HCT): associations between viral load in bronchoalveolar lavage samples, viral RNA detection in serum samples, and clinical outcomes of HCTAngela P Campbell
Department of Pediatrics, University of Washington, Seattle, Washington, USA
J Infect Dis 201:1404-13. 2010..Few data exist on respiratory virus quantitation in lower respiratory samples and detection in serum from hematopoietic cell transplant (HCT) recipients with respiratory virus-associated pneumonia...
Incidence and clinical features of ganciclovir-resistant cytomegalovirus disease in heart transplant recipientsFanny Li
Department of Pharmacy Services, University of Washington, Seattle, WA 98195, USA
Clin Infect Dis 45:439-47. 2007..The incidence and clinical and virologic aspects of ganciclovir-resistant cytomegalovirus (CMV) disease have not been well-characterized in heart transplant recipients...
Immune evasion proteins of human cytomegalovirus do not prevent a diverse CD8+ cytotoxic T-cell response in natural infectionThomas J Manley
Fred Hutchinson Cancer Research Center, D3 100, 1100 Fairview Ave N, Seattle, WA 98109, USA
Blood 104:1075-82. 2004..Thus, reconstitution of T-cell immunity in immunodeficient patients by cell therapy or by vaccination may need to target multiple viral antigens to completely restore immunologic control of CMV...
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimenH Joachim Deeg
Fred Hutchinson Cancer Research Center and University of Washington School of Medicine, Seattle, Washington 98109 1024, USA
Biol Blood Marrow Transplant 12:573-84. 2006....
Impact of HLA A2 and cytomegalovirus serostatus on outcomes in patients with leukemia following matched-sibling myeloablative allogeneic hematopoietic cell transplantationVeronique Erard
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Haematologica 91:1377-83. 2006....
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioningFrederic Baron
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 6072, USA
Biol Blood Marrow Transplant 12:1176-87. 2006..Other factors significantly associated with delayed immune recovery were advanced donor age, low numbers of CD34 and T cells in the graft, and development of graft-versus-host disease...
Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioningMichael Maris
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 1024, USA
Exp Hematol 31:941-52. 2003..We studied immune reconstitution in 51 recipients of HLA-identical hematopoietic cellular transplant (HCT) after nonmyeloablative conditioning compared to a reference group of 67 recipients after myeloablative conditioning...
Pretransplantation respiratory syncytial virus infection: impact of a strategy to delay transplantationAngela J Peck
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Clin Infect Dis 39:673-80. 2004....
Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplantsKieren A Marr
Program of Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Blood 103:1527-33. 2004..69). There was no difference in overall or fungal-free survival. Itraconazole appears to prevent IMI in the subset of patients who tolerate the drug; however, toxicities and poor tolerability limit its success as prophylactic therapy...
Prolonged outbreak of human parainfluenza virus 3 infection in a stem cell transplant outpatient department: insights from molecular epidemiologic analysisW Garrett Nichols
Fred Hutchinson Cancer Research Center, Seattle, Washington 98109 4417, USA
Biol Blood Marrow Transplant 10:58-64. 2004..The concept of nosocomial transmission should be expanded to include the OPD for immunosuppressed patients...
Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implicationsW Garrett Nichols
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, University of Washington, 1100 Fairview Avenue N, D3 100, Seattle, WA 98109 4417, USA
J Infect Dis 187:801-8. 2003..Serological testing of donors can identify patients who are at highest risk for HSV-related morbidity, for whom prolonged prophylaxis or donor vaccination (once available) could be considered...
Cyclophosphamide metabolism is affected by azole antifungalsKieren A Marr
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, D3 100, Seattle, WA 98109, USA
Blood 103:1557-9. 2004..These data suggest that azole antifungals, through differential inhibition of hepatic cytochrome P-450 isoenzymes, affect CY metabolism and conditioning-related toxicities...
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantationJ Storek
Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA 98109 1024, USA
Bone Marrow Transplant 33:337-46. 2004..In contrast, neither recipient immunization on days -1 and 50 nor donor immunization on day -20 appears to be efficacious for polysaccharide antigens and poorly immunogenic protein neo-antigens...
How I treat influenza in patients with hematologic malignanciesCorey Casper
Vaccine and Infectious Disease Institute, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Blood 115:1331-42. 2010..We also summarize infection control and vaccination strategies for patients, family members, and caregivers...
Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant centerTakahiro Fukuda
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109-1024, USA
Biol Blood Marrow Transplant 10:494-503. 2004....
Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantationPierre Yves Bochud
Institute for Systems Biology, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
N Engl J Med 359:1766-77. 2008..We examined the role of TLR polymorphisms in conferring a risk of invasive aspergillosis among recipients of allogeneic hematopoietic-cell transplants...
An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patientsAmanda L Adler
Department of Pediatrics, University of Washington, Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
Infect Control Hosp Epidemiol 29:866-70. 2008..We describe an outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients in October 2004...
BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitisVeronique Erard
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA
Clin Infect Dis 39:1861-5. 2004..7x10(3) vs. 0 copies/mL; P=.0006). BK viremia also was strongly associated with postengraftment hemorrhagic cystitis in a time-dependent analysis (P=.004)...
Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapyW Garrett Nichols
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 4417, USA
Clin Infect Dis 39:1300-6. 2004..Risk factors for acquisition, progression to pneumonia, and the effect of antiviral therapy are unknown...
DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipientD R Drozd
Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington 98195 6175, USA
Transpl Infect Dis 15:E28-32. 2013..Treatment was well tolerated and associated with improvement in oxygenation and symptoms, along with rapid clearance of PIV. DAS181 should be systematically evaluated for treatment of PIV infection in transplant recipients...
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantationChien-Shing Chen
Clinical Research Division, Fred Hutchinson Cancer Research Center and the University of Washington, School of Medicine Seattle, WA, USA
Bone Marrow Transplant 32:515-22. 2003..5, P=0.007). Our data suggest that extension of PCP prophylaxis may be beneficial in high-risk autograft recipients. Further study of long-term anti-infective prophylaxis based on patient risk factors after SCT appear warranted...
Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantationM Hakki
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Bone Marrow Transplant 39:687-93. 2007..aeruginosa infections are associated with high recurrence rates and mortality in this immunocompromised population. Aggressive attempts to reduce immunosuppression and to treat copathogens may help during the initial infection...
Adenovirus nephritis in hematopoietic stem-cell transplantationBenedetto Bruno
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-4417, USA
Transplantation 77:1049-57. 2004..ADV infection was a major cause of death in 17 patients. CONCLUSIONS: ADV nephritis is a specific renal complication in HSCT patients that can be diagnosed by renal biopsy in patients with hematuria and adenoviruria...
Specific delineation of BK polyomavirus in kidney tissue with a digoxigenin-labeled DNA probeRachael K Parkin
Division of Clinical Research, Fred Hutchinson Cancer Research Center, P O Box 19024 1100, Fairview Ave N D2 190, Seattle, WA 98109 1024, USA
Mol Cell Probes 19:87-92. 2005..Alternatively, high stringency hybridization conditions may be utilized, detecting BKV only. BK associated tubular necrosis is clearly demonstrated in two cases of BK nephritis...
Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantationJason W Chien
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
Blood 111:2462-9. 2008..83; 95% CI, 1.38-16.75, P = .013). These data suggest that transcriptional regulation of the LBP gene contributes to the risk for developing GN bacteremia and death after HCT...
Research Grants
- Respiratory Viruses and Airflow Obstruction after HCTMichael Boeckh; Fiscal Year: 2007..These studies will improve our understanding of the interaction between respiratory viruses and late pulmonary complications after HCT, which will ultimately enable us to formulate more rational treatment strategies. ..
